Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.

Bounthavong, Mark; Butler, Javed; Dolan, Chantal M; Dunn, Jeffrey D; Fisher, Kathryn A; Oestreicher, Nina; Pitt, Bertram; Hauptman, Paul J; Veenstra, David L

Bounthavong, Mark; Butler, Javed; Dolan, Chantal M; Dunn, Jeffrey D; Fisher, Kathryn A; Oestreicher, Nina; Pitt, Bertram; Hauptman, Paul J; Veenstra, David L.

Afiliação

Bounthavong M; Department of Pharmacy, University of Washington, 1959 NE Pacific St, HSB H375-P, Box 357630, Seattle, WA, 98195-7630, USA.
Butler J; Division of Cardiology, Stony Brook University, Stony Brook, NY, USA.
Dolan CM; CMD Consulting, Sandy, UT, USA.
Dunn JD; Magellan Rx, Salt Lake City, UT, USA.
Fisher KA; CMD Consulting, Sandy, UT, USA.
Oestreicher N; Epidemiology, HEOR and Observational Research, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USA.
Pitt B; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
Hauptman PJ; University of Michigan School of Medicine, Ann Arbor, MI, USA.
Veenstra DL; Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, Saint Louis, MI, USA.

Pharmacoeconomics ; 37(8): 1071, 2019 Aug.

Article em En | MEDLINE | ID: mdl-31089966

RESUMO

Correction to Bounthavong M, Butler J, Dolan CM, Dunn JD, Fisher KA, Oestreicher N, Pitt B, Hauptman PJ, Veenstra DL.

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Pharmacoeconomics Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google